Fluorofenidone Affects Hepatic Stellate Cell Activation in Hepatic Fibrosis by Targeting the TGF‑β1/Smad and MAPK Signaling Pathways

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2019.7548

Related search